PPAR agonist program (Albireo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePPAR agonist program (Albireo)
Drug Alias Nameperoxisome proliferation activated receptor agonist program (Albireo)AS-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbireo Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbireo LtdAlbireo Pharma Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A